Updated: Jan 19, 2020
New tests are starting to be available to optimize therapies for canine patients. After all, each dog's cancer is unique. A drug that works for one dog may not necessarily work for another because their cancer cells are different. So we need to get away from today's one-size-fits-all therapeutics to more personalized treatments.
Our blog series will start this weekend by focusing on new personalized medicine treatments. (It's also sometimes called precision medicine). Precision medicine is widely available to human cancer patients but was introduced to our pets only recently. We'll be describing several companies with new diagnostic tests to help choose best drugs for canine patients. We'll also be sharing information about a new personalized immunotherapy clinical trial.
Our hope is that this information will help pet owners choose the best options for their pets. We also hope that these trials will gather sufficient data and scientific evidence for safety and efficacy, and the treatments will ultimately become widely available to pet parents.